Medigen Vaccine Biologics (6547) — Cash Flow-to-Debt Ratio
Medigen Vaccine Biologics (6547) has a Cash Flow-to-Debt Ratio of 0.22x as of December 2025, meaning its operating cash flow of NT$101.08 Million could theoretically repay 0% of its total liabilities (NT$454.64 Million) in one year. Check Medigen Vaccine Biologics investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medigen Vaccine Biologics Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Medigen Vaccine Biologics across 14 annual periods. Also explore balance sheet size of Medigen Vaccine Biologics for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Medigen Vaccine Biologics (2012–2025)
Year-by-year debt coverage analysis for Medigen Vaccine Biologics. For market capitalisation and broader financial context, see 6547 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | NT$-49.09 Million | NT$454.64 Million | ▼ -236.2% |
| 2024 | 0.08x | NT$40.75 Million | NT$513.92 Million | ▲ +137.3% |
| 2023 | -0.21x | NT$-477.75 Million | NT$2.25 Billion | ▲ +55.2% |
| 2022 | -0.47x | NT$-1.10 Billion | NT$2.32 Billion | ▼ -151.0% |
| 2021 | 0.93x | NT$579.89 Million | NT$622.95 Million | ▲ +155.1% |
| 2020 | -1.69x | NT$-589.97 Million | NT$349.40 Million | ▼ -232.2% |
| 2019 | -0.51x | NT$-462.65 Million | NT$910.28 Million | ▲ +18.5% |
| 2018 | -0.62x | NT$-356.33 Million | NT$571.10 Million | ▼ -76.9% |
| 2017 | -0.35x | NT$-217.03 Million | NT$615.41 Million | ▲ +24.9% |
| 2016 | -0.47x | NT$-163.37 Million | NT$347.90 Million | ▼ -167.1% |
| 2015 | 0.70x | NT$216.26 Million | NT$309.19 Million | ▲ +118.5% |
| 2014 | -3.78x | NT$-513.98 Million | NT$135.95 Million | ▼ -1.7% |
| 2013 | -3.72x | NT$-72.36 Million | NT$19.46 Million | ▼ -1404.9% |
| 2012 | -0.25x | NT$-5.47 Million | NT$22.15 Million | — |